Stock listing
OTC:GTHP Guided Therapeutics, Inc. Stock
Follow Guided Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · OTC:GTHP
$0.10 USD -0.01 (-9.1%)
Close on Nov 20, 2026
- Day range
- $0.10 – $0.10 USDNov 20, 2026
- Volume
- 4,292 sharesNov 20, 2026
- Market cap
- $9.65M USDAt the close on Nov 20, 2026 · price × 96.54M shares outstanding
- 52-week range
- $0.10 – $0.54 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $6,810 USDMedian day 6,600 shares · 11 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:GTHP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.10 | -0.01 | -9.1% | $0.10 | $0.10 | $0.10 | 4,292 | |
| $0.11 | +0.008 | +7.8% | $0.11 | $0.11 | $0.11 | 7,600 | |
| $0.102 | -0.008 | -7.3% | $0.11 | $0.11 | $0.101 | 34,000 | |
| $0.11 | 0.00 | 0.0% | $0.11 | $0.11 | $0.11 | 3,200 | |
| $0.11 | -0.01 | -8.3% | $0.10 | $0.11 | $0.10 | 11,800 | |
| $0.12 | +0.019 | +18.8% | $0.11 | $0.12 | $0.11 | 102,600 | |
| $0.101 | -0.009 | -8.2% | $0.11 | $0.11 | $0.10 | 21,500 | |
| $0.11 | 0.00 | 0.0% | $0.138 | $0.138 | $0.10 | 107,800 | |
| $0.11 | +0.01 | +10.0% | $0.10 | $0.138 | $0.10 | 144,364 | |
| $0.10 | 0.00 | 0.0% | $0.109 | $0.109 | $0.10 | 56,000 | |
| $0.10 | -0.008 | -7.4% | $0.13 | $0.13 | $0.10 | 58,000 | |
| $0.108 | -0.042 | -28.0% | $0.12 | $0.13 | $0.10 | 299,500 | |
| $0.15 | +0.013 | +9.5% | $0.15 | $0.15 | $0.15 | 500 | |
| $0.137 | -0.013 | -8.7% | $0.13 | $0.137 | $0.13 | 276,000 | |
| $0.15 | +0.005 | +3.4% | $0.15 | $0.15 | $0.147 | 7,200 | |
| $0.145 | -0.002 | -1.4% | $0.147 | $0.147 | $0.145 | 1,000 | |
| $0.147 | +0.002 | +1.4% | $0.15 | $0.15 | $0.147 | 2,000 | |
| $0.145 | +0.013 | +9.8% | $0.15 | $0.15 | $0.145 | 1,100 | |
| $0.132 | -0.013 | -9.0% | $0.132 | $0.132 | $0.132 | 1,000 | |
| $0.145 | -0.025 | -14.7% | $0.17 | $0.17 | $0.145 | 10,300 | |
| $0.17 | +0.02 | +13.3% | $0.15 | $0.17 | $0.148 | 22,300 | |
| $0.15 | -0.04 | -21.1% | $0.137 | $0.232 | $0.137 | 13,400 | |
| $0.19 | +0.03 | +18.8% | $0.16 | $0.195 | $0.155 | 154,200 | |
| $0.16 | -0.03 | -15.8% | $0.18 | $0.18 | $0.15 | 310,800 | |
| $0.19 | 0.00 | 0.0% | $0.19 | $0.19 | $0.19 | 100 | |
| $0.19 | 0.00 | 0.0% | $0.19 | $0.19 | $0.19 | 600 | |
| $0.19 | 0.00 | 0.0% | $0.19 | $0.19 | $0.19 | 0 | |
| $0.19 | 0.00 | 0.0% | $0.19 | $0.19 | $0.19 | 0 | |
| $0.19 | +0.01 | +5.6% | $0.19 | $0.19 | $0.19 | 3,500 | |
| $0.18 | -0.02 | -10.0% | $0.20 | $0.20 | $0.18 | 15,700 | |
| $0.20 | -0.03 | -13.0% | $0.229 | $0.235 | $0.20 | 22,300 | |
| $0.23 | +0.028 | +13.9% | $0.22 | $0.23 | $0.22 | 15,000 | |
| $0.202 | 0.00 | 0.0% | $0.202 | $0.202 | $0.202 | 0 | |
| $0.202 | -0.018 | -8.2% | $0.20 | $0.202 | $0.181 | 40,500 | |
| $0.22 | -0.028 | -11.3% | $0.18 | $0.24 | $0.18 | 18,300 | |
| $0.248 | 0.00 | 0.0% | $0.248 | $0.248 | $0.248 | 0 | |
| $0.248 | +0.048 | +24.0% | $0.248 | $0.248 | $0.248 | 100 | |
| $0.20 | +0.02 | +11.1% | $0.248 | $0.248 | $0.19 | 23,500 | |
| $0.18 | -0.068 | -27.4% | $0.185 | $0.185 | $0.17 | 745,900 | |
| $0.248 | +0.003 | +1.2% | $0.182 | $0.248 | $0.182 | 21,100 | |
| $0.245 | 0.00 | 0.0% | $0.245 | $0.245 | $0.245 | 0 | |
| $0.245 | +0.025 | +11.4% | $0.22 | $0.245 | $0.22 | 2,700 | |
| $0.22 | 0.00 | 0.0% | $0.22 | $0.22 | $0.22 | 1,500 | |
| $0.22 | -0.01 | -4.3% | $0.232 | $0.232 | $0.22 | 2,300 | |
| $0.23 | 0.00 | 0.0% | $0.23 | $0.23 | $0.23 | 0 | |
| $0.23 | -0.02 | -8.0% | $0.223 | $0.23 | $0.223 | 5,200 | |
| $0.25 | 0.00 | 0.0% | $0.25 | $0.25 | $0.25 | 0 | |
| $0.25 | 0.00 | 0.0% | $0.22 | $0.25 | $0.22 | 1,900 | |
| $0.25 | 0.00 | 0.0% | $0.25 | $0.25 | $0.25 | 0 | |
| $0.25 | 0.00 | 0.0% | $0.25 | $0.25 | $0.25 | 0 | |
| $0.25 | 0.00 | 0.0% | $0.25 | $0.25 | $0.25 | 0 | |
| $0.25 | +0.05 | +25.0% | $0.20 | $0.25 | $0.182 | 45,400 | |
| $0.20 | 0.00 | 0.0% | $0.20 | $0.20 | $0.20 | 8,700 | |
| $0.20 | -0.038 | -16.0% | $0.25 | $0.25 | $0.20 | 7,800 | |
| $0.238 | -0.012 | -4.8% | $0.24 | $0.25 | $0.215 | 6,600 | |
| $0.25 | +0.04 | +19.0% | $0.19 | $0.25 | $0.19 | 30,300 | |
| $0.21 | -0.015 | -6.7% | $0.21 | $0.21 | $0.21 | 10,000 | |
| $0.225 | -0.007 | -3.0% | $0.23 | $0.23 | $0.225 | 2,300 | |
| $0.232 | -0.003 | -1.3% | $0.232 | $0.232 | $0.232 | 1,100 | |
| $0.235 | -0.015 | -6.0% | $0.235 | $0.235 | $0.21 | 3,500 | |
| $0.25 | 0.00 | 0.0% | $0.25 | $0.25 | $0.25 | 0 | |
| $0.25 | 0.00 | 0.0% | $0.24 | $0.25 | $0.18 | 74,600 | |
| $0.25 | -0.02 | -7.4% | $0.25 | $0.25 | $0.25 | 1,400 | |
| $0.27 | 0.00 | 0.0% | $0.27 | $0.27 | $0.27 | 100 | |
| $0.27 | +0.053 | +24.4% | $0.19 | $0.27 | $0.19 | 24,500 |
Splits
2 splits since 2016 · OTC:GTHP · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-800 | Consolidation | |
| 1-for-800 | Consolidation |
- Ticker
- OTC:GTHP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 4, 2026
Guided Therapeutics Provides Update on its Cervical Cancer Screening Study with Türkiye’s Ministry of Health
Latest news
Guided Therapeutics Provides Update on its Cervical Cancer Screening Study with Türkiye’s Ministry of Health
Nov 4, 2026
Closed $0.108 (-28.0%) on Nov 4, 2026
Guided Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 1 in the last 12 months · 1 in all · newest Nov 4, 2026 · oldest 2026
- Decks
- 9 decks · latest 2015
Valuation
EV/sales 14.2× against a median of 2.3×: 7th lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $9.68M USD
- P/E
- Loss
- EV/sales
- 14.2×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- 80.2%
- Operating margin
- −304.0%
- Net margin
- −445.9%
- Debt to equity
- Negative equity
- Beta vs S&P 500
- -0.75
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Guided Therapeutics, Inc. · OTC:GTHP | US$9.65M | US$9.68M | n/a | 14.2× | n/a | n/a | −445.9% | n/a | -0.75 |
| Health & Life Co., Ltd. · TPEX:1781 | US$10.94M | US$10.04M | n/a | 0.8× | n/a | 1.2× | −12.7% | 0.6× | n/a |
| Femasys Inc. · NASDAQ:FEMY | US$10.73M | −US$8.31M | n/a | −4.2× | n/a | 0.4× | −614.7% | 0.2× | 1.60 |
| ADM Tronics Unlimited, Inc. · OTC:ADMT | US$9.97M | US$9.77M | n/a | 3.0× | n/a | 13.4× | −4.3% | 0.0× | -1.45 |
| United Health Products, Inc. · OTC:UEEC | US$9.69M | US$9.69M | n/a | n/a | n/a | n/a | n/a | n/a | -0.09 |
| Nestmedic SA · NEWCONNECT:NST | US$9.64M | US$9.23M | n/a | 38.8× | n/a | 3.2× | −413.6% | 0.0× | n/a |
| EPS Bio Technology Corp. · TPEX:4183 | US$9.57M | US$5.77M | n/a | 0.4× | 21.4× | 1.2× | −1.6% | 0.0× | n/a |
| VVT Med Inc. · TSXV:VVTM | US$8.99M | US$8.99M | n/a | 93.6× | n/a | n/a | n/a | n/a | 1.16 |
| SpineGuard · EURONEXT:ALSGD | US$8.88M | US$9.65M | n/a | 2.3× | n/a | 1.8× | −55.0% | 0.3× | n/a |
| Pulsenmore Ltd. · TASE:PLSM | US$8.75M | US$2.28M | n/a | 0.2× | n/a | 0.3× | −39.6% | 0.0× | n/a |
| Conavi Medical Corp. · TSXV:CNVI | US$8.66M | US$8.89M | n/a | 15.1× | n/a | n/a | n/a | n/a | 0.36 |
| Median of the others | US$9.60M | US$9.11M | 2.3× | 21.4× | 1.2× | −39.6% | 0.0× | 0.36 |
Team and board
Officers
| Officer | Role |
|---|---|
| Mark L. Faupel | President and CEO, Board Member |
Board
| Director | Role |
|---|---|
| Alan Grujic | Board Member |
| Mark L. Faupel | President and CEO, Board Member |
| Richard P. Blumberg | Board Member |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2025 | Aug 14, 2025 | +41.0% |
| Q1 2025 | May 12, 2025 · After close | −4.8% |
| Q4 2024 | Mar 26, 2025 · After close | +19.9% |
| Q3 2024 | Nov 11, 2024 · After close | −7.7% |
| Q2 2024 | Aug 14, 2024 · After close | +0.1% |
| Q1 2024 | May 13, 2024 · After close | +15.3% |
| Q4 2023 | Mar 28, 2024 · After close | +3.5% |
| Q3 2023 | Nov 13, 2023 | −3.9% |
| Q2 2023 | Aug 15, 2023 | +3.6% |
| Q1 2023 | May 15, 2023 | +11.7% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2022 | Mar 10, 2023 | 0.0% |
| Q3 2022 | Nov 11, 2022 | −14.3% |
| Q2 2022 | Aug 11, 2022 | +5.8% |
| Q1 2022 | May 19, 2022 | −17.4% |
| Q4 2021 | Mar 15, 2022 | −5.8% |
| Quarter to Sep 30, 2021 | Nov 12, 2021 | −10.8% |
| Quarter to Jun 30, 2021 | Aug 12, 2021 | +60.0% |
| Quarter to Mar 31, 2021 | May 20, 2021 | +1.3% |
| Quarter to Dec 31, 2020 | Mar 16, 2021 | +2.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (2015) | Technical | 20 slides | 2015 |
| Technical Presentation (2014) | Technical | 40 slides | 2014 |
| Technical Presentation (2012) | Technical | 35 slides | Oct 4, 2012 |
| ASCCP 2010 | Conference | 21 slides | 2010 |
| Technical Presentation (2010) | Technical | 18 slides | 2010 |
| Technical Presentation (2010) | Technical | 13 slides | 2010 |
| Technical Presentation (2007) | Technical | 35 slides | 2007 |
| Technical Presentation (2006) | Technical | 18 slides | 2006 |
| EUROGIN 2003 | Conference | 18 slides | 2003 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 767.0K | 7.00K | 98.0K | 13.0K | 81.0K | 102.0K | 36.0K | 57.0K | 244.0K | 0 |
| Cost of revenue | 196.0K | 5.00K | 62.0K | 81.0K | 61.0K | -41.0K | 70.0K | 89.0K | 530.0K | 493.0K |
| Gross profit | 571.0K | 2.00K | 36.0K | -68.0K | 20.0K | 143.0K | -34.0K | -32.0K | -286.0K | 112.0K |
| Research and development | 469.0K | 526.0K | 228.0K | 77.0K | 69.0K | 143.0K | 122.0K | 244.0K | 334.0K | 733.0K |
| Operating income | -2.37M | -2.11M | -3.46M | -3.33M | -2.36M | -1.05M | -937.0K | -1.55M | -3.12M | -3.82M |
| Depreciation and amortization | 10.0K | 9.00K | 9.00K | 4.00K | 1.00K | 0 | 21.0K | 27.0K | 213.0K | 1.22M |
| EBITDA | -2.36M | -2.10M | -3.45M | -3.33M | -2.36M | -1.05M | -916.0K | -1.52M | -2.91M | -2.60M |
| Interest expense | 617.0K | 381.0K | 278.0K | 582.0K | 1.15M | 1.06M | 1.41M | 1.76M | 1.11M | 1.90M |
| Income before tax | -3.20M | -2.42M | -3.49M | -4.34M | -2.07M | -279.0K | -1.92M | 1.02M | -10.7M | -3.97M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -3.20M | -2.42M | -3.49M | -4.34M | -2.07M | -279.0K | -1.92M | 1.02M | -10.7M | -3.97M |
| Earnings per share, basic | -0.04 | -0.05 | -0.07 | -0.15 | -0.18 | -0.04 | -0.58 | 1.95 | 997.64 | -24.62 |
| Earnings per share, diluted | -0.04 | -0.05 | -0.07 | -0.15 | -0.18 | -0.04 | -0.58 | 0.01 | 0.00 | -24.62 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 63.0K | 388.0K | 591.0K | 2.31M | 643.0K | 182.0K | 899.0K | 0 | 1.00K | 14.0K |
| Receivables | 4.00K | 3.00K | 7.00K | 6.00K | 46.0K | |||||
| Inventory | 448.0K | 633.0K | 632.0K | 548.0K | 571.0K | 605.0K | 48.0K | 114.0K | 182.0K | 773.0K |
| Current assets | 605.0K | 1.20M | 1.39M | 3.00M | 1.64M | 896.0K | 1.03M | 196.0K | 297.0K | 1.05M |
| Property, plant and equipment | 16.0K | 23.0K | 32.0K | 42.0K | 14.0K | 1.00K | 0 | 21.0K | 49.0K | 126.0K |
| Total assets | 1.32M | 1.38M | 1.67M | 3.37M | 2.04M | 1.35M | 1.18M | 236.0K | 406.0K | 1.49M |
| Accounts payable | 2.42M | 2.09M | 1.99M | 2.19M | 2.36M | 2.42M | 2.90M | 3.01M | 3.02M | 2.60M |
| Current liabilities | 6.64M | 6.16M | 4.81M | 4.87M | 5.69M | 8.96M | 12.4M | 11.0M | 11.8M | 9.34M |
| Long-term debt | 0 | 22.0K | 23.0K | 0 | ||||||
| Total debt | 0 | 17.0K | 22.0K | 23.0K | 6.35M | 5.74M | 9.05M | |||
| Total liabilities | 7.33M | 6.27M | 5.47M | 6.25M | 7.49M | 12.2M | 18.1M | 16.1M | 19.8M | 10.8M |
| Shareholders' equity | -6.01M | -4.89M | -3.81M | -2.88M | -5.45M | -10.9M | -16.9M | -15.8M | -19.4M | -9.27M |
| Shares outstanding | 86.2K | 65.1M | 54.1M | 48.6M | 13.7M | 13.1M | 3.32K | 2.67K | 62.0K | 669 |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.07M | -1.12M | -1.75M | -1.48M | -1.59M | -1.88M | -806.0K | -1.36M | -1.14M | -1.80M |
| Capital spending | -2.00K | 0 | 0 | -31.0K | -14.0K | -1.00K | 0 | 0 | ||
| Free cash flow | -1.07M | -1.12M | -1.75M | -1.51M | -1.61M | -1.88M | -806.0K | -1.80M | ||
| Cash from investing | -2.00K | 0 | -31.0K | -14.0K | -1.00K | 0 | 0 | |||
| Cash from financing | 745.0K | 916.0K | 24.0K | 3.18M | 2.07M | 1.16M | 1.71M | 1.36M | 1.13M | 1.78M |
| Change in cash | -325.0K | -203.0K | -1.72M | 1.67M | 461.0K | -717.0K | 899.0K | -1.00K | -13.0K | -21.0K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 16, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 27, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 10-Q · Quarterly report | May 15, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | May 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 7, 2026 | Insider trade | SEC |
| 10-K · Annual report | Mar 30, 2026 | Annual report | SEC |
| 4 · Change in ownership | Mar 12, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Mar 9, 2026 | Material contract | SEC |
| 4 · Change in ownership | Mar 4, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Sep 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Jun 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | May 23, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Apr 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 8, 2025 | Insider trade | SEC |
| 10-K · Annual report | Mar 31, 2025 | Annual report | SEC |
| 4 · Change in ownership | Feb 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 20, 2024 | Insider trade | SEC |
| 8-K · Current report | Dec 20, 2024 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 26, 2024 | Material contract | SEC |
| 4 · Change in ownership | Sep 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 1, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 13, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Apr 19, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 5, 2024 | Insider trade | SEC |
| 10-K · Annual report | Mar 28, 2024 | Annual report | SEC |
| 4 · Change in ownership | Mar 22, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 22, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 20, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 8, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Sep 20, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 11, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 7, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 10, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Jun 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 26, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 20, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | May 15, 2023 | Quarterly report | SEC |
| 10-K · Annual report | Mar 29, 2023 | Annual report | SEC |
| 8-K · Current report | Mar 9, 2023 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| EFFECT · Notice that a registration is effective | Jan 26, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 23, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jan 23, 2023 | Other filings | SEC |
| S-1 · Registration statement | Jan 13, 2023 | Offer document | SEC |
| RW · Request to withdraw a registration | Dec 2, 2022 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| SC 13G · Big-stake notice | Oct 24, 2022 | Big-stake notice | SEC |
| 8-K · Current report | Sep 15, 2022 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 15, 2022 | Quarterly report | SEC |
| 8-K · Current report | Jul 29, 2022 | Current report | SEC |
| S-1/A · Registration statement, amended | Jul 12, 2022 | Offer document | SEC |
| SC 13G · Big-stake notice | Jul 6, 2022 | Big-stake notice | SEC |
| S-1/A · Registration statement, amended | Jun 29, 2022 | Offer document | SEC |
| 10-Q · Quarterly report | May 16, 2022 | Quarterly report | SEC |
| 10-K · Annual report | Mar 29, 2022 | Annual report | SEC |
| S-1/A · Registration statement, amended | Feb 17, 2022 | Offer document | SEC |
| 8-K · Current report | Jan 6, 2022 | Current report | SEC |
| 10-Q · Quarterly report | Nov 15, 2021 | Quarterly report | SEC |
| S-1/A · Registration statement, amended | Oct 6, 2021 | Offer document | SEC |
| S-1 · Registration statement | Sep 28, 2021 | Offer document | SEC |
| 8-K · Current report | Sep 3, 2021 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 18, 2021 | Quarterly report | SEC |
| 10-Q/A · Quarterly report, amended | Aug 18, 2021 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 16, 2021 | Explanation request | SEC |
| 8-K · Current report | Jul 27, 2021 | Meeting outcome | SEC |
| 10-K/A · Annual report, amended | Jul 9, 2021 | Annual report | SEC |
| 8-K · Current report | Jul 7, 2021 | Current report | SEC |
| DEF 14A · Proxy statement | Jul 2, 2021 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Jun 21, 2021 | Meeting notice | SEC |
| 8-K · Current report | Jun 10, 2021 | Material contract | SEC |
| 10-Q · Quarterly report | May 20, 2021 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 17, 2021 | Explanation request | SEC |
| 10-K · Annual report | Apr 6, 2021 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2021 | Explanation request | SEC |
| 10-Q/A · Quarterly report, amended | Nov 5, 2020 | Quarterly report | SEC |
| 10-Q · Quarterly report | Nov 5, 2020 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Oct 16, 2020 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 13, 2020 | Other filings | SEC |
| S-1/A · Registration statement, amended | Oct 7, 2020 | Offer document | SEC |
| 8-K · Current report | Sep 16, 2020 | Management or board change | SEC |
| UPLOAD · Letter from the SEC | Sep 14, 2020 | Other filings | SEC |
| S-1 · Registration statement | Sep 10, 2020 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 19, 2020 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 17, 2020 | Explanation request | SEC |
| 10-Q · Quarterly report | Jul 7, 2020 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Jun 29, 2020 | Explanation request | SEC |
| 8-K · Current report | May 18, 2020 | Current report | SEC |
| 10-K · Annual report | Apr 20, 2020 | Annual report | SEC |
| 8-K · Current report | Mar 31, 2020 | Current report | SEC |
| 10-Q · Quarterly report | Mar 9, 2020 | Quarterly report | SEC |
| 10-Q · Quarterly report | Feb 11, 2020 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 15, 2019 | Explanation request | SEC |
| 10-Q · Quarterly report | Jul 11, 2019 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 15, 2019 | Explanation request | SEC |
| 10-K · Annual report | May 8, 2019 | Annual report | SEC |
| 8-K · Current report | Apr 3, 2019 | Management or board change | SEC |
| NT 10-K · Late filing notice | Apr 1, 2019 | Explanation request | SEC |
| 8-K · Current report | Nov 14, 2018 | Current report | SEC |
| 10-Q · Quarterly report | Nov 14, 2018 | Quarterly report | SEC |
| 8-K · Current report | Oct 25, 2018 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Oct 11, 2018 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Sep 28, 2018 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Sep 17, 2018 | Meeting notice | SEC |
| 8-K · Current report | Sep 6, 2018 | Material contract | SEC |
| PRE 14A · Preliminary proxy statement | Sep 5, 2018 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 14, 2018 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Jul 11, 2018 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 9, 2018 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 2, 2018 | Other filings | SEC |
| S-1 · Registration statement | Jun 14, 2018 | Offer document | SEC |
| SC 13D · Big-stake notice | May 25, 2018 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | May 25, 2018 | Insider trade | SEC |
| 10-Q · Quarterly report | May 21, 2018 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 15, 2018 | Explanation request | SEC |
| 10-K/A · Annual report, amended | Apr 20, 2018 | Annual report | SEC |
| 10-K · Annual report | Apr 17, 2018 | Annual report | SEC |
| NT 10-K · Late filing notice | Apr 2, 2018 | Explanation request | SEC |
| 10-Q · Quarterly report | Nov 20, 2017 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 15, 2017 | Explanation request | SEC |
| 8-K/A · Current report, amended | Nov 9, 2017 | Material contract | SEC |
| 8-K · Current report | Oct 25, 2017 | Material contract | SEC |
| RW · Request to withdraw a registration | Sep 25, 2017 | Other filings | SEC |
| 8-K · Current report | Aug 24, 2017 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 18, 2017 | Quarterly report | SEC |
| 8-K/A · Current report, amended | Aug 17, 2017 | Material contract | SEC |
| NT 10-Q · Late filing notice | Aug 15, 2017 | Explanation request | SEC |
| 8-K · Current report | Aug 14, 2017 | Material contract | SEC |
| S-1/A · Registration statement, amended | Jun 26, 2017 | Offer document | SEC |
| S-1/A · Registration statement, amended | Jun 7, 2017 | Offer document | SEC |
| 8-K · Current report | May 23, 2017 | Material contract | SEC |
| 10-Q · Quarterly report | May 19, 2017 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 15, 2017 | Explanation request | SEC |
| S-1/A · Registration statement, amended | Mar 31, 2017 | Offer document | SEC |
| 424B3 · Prospectus | Mar 30, 2017 | Offer document | SEC |
| 8-K · Current report | Mar 30, 2017 | Material contract | SEC |
| 424B3 · Prospectus | Mar 24, 2017 | Offer document | SEC |
| 8-K/A · Current report, amended | Mar 24, 2017 | Material contract | SEC |
| 10-K · Annual report | Mar 22, 2017 | Annual report | SEC |
| SC 13G · Big-stake notice | Mar 9, 2017 | Big-stake notice | SEC |
| 424B3 · Prospectus | Feb 16, 2017 | Offer document | SEC |
| 8-K · Current report | Feb 16, 2017 | Material contract | SEC |
| 424B3 · Prospectus | Jan 26, 2017 | Offer document | SEC |
| 8-K · Current report | Jan 26, 2017 | Material contract | SEC |
| S-1/A · Registration statement, amended | Jan 12, 2017 | Offer document | SEC |
| 424B3 · Prospectus | Dec 30, 2016 | Offer document | SEC |
| 8-K · Current report | Dec 30, 2016 | Material contract | SEC |
| S-1/A · Registration statement, amended | Dec 8, 2016 | Offer document | SEC |
| 424B3 · Prospectus | Dec 8, 2016 | Offer document | SEC |
| 8-K · Current report | Dec 8, 2016 | Management or board change | SEC |
| 424B3 · Prospectus | Dec 7, 2016 | Offer document | SEC |
| 8-K · Current report | Dec 7, 2016 | Material contract | SEC |
| 424B3 · Prospectus | Dec 5, 2016 | Offer document | SEC |
| 10-Q · Quarterly report | Dec 5, 2016 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Nov 18, 2016 | Insider trade | SEC |
| 424B3 · Prospectus | Nov 17, 2016 | Offer document | SEC |
| 8-K · Current report | Nov 17, 2016 | Management or board change | SEC |
| NT 10-Q · Late filing notice | Nov 15, 2016 | Explanation request | SEC |
| 424B3 · Prospectus | Nov 4, 2016 | Offer document | SEC |
| 8-K · Current report | Nov 4, 2016 | Material contract | SEC |
| 424B3 · Prospectus | Sep 23, 2016 | Offer document | SEC |
| 8-K · Current report | Sep 23, 2016 | Meeting outcome | SEC |
| 424B3 · Prospectus | Sep 9, 2016 | Offer document | SEC |
| 8-K/A · Current report, amended | Sep 9, 2016 | Material contract | SEC |
| 424B3 · Prospectus | Sep 8, 2016 | Offer document | SEC |
| 8-K · Current report | Sep 8, 2016 | Material contract | SEC |
| DEFA14A · Additional proxy material | Aug 26, 2016 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Aug 25, 2016 | Meeting notice | SEC |
| UPLOAD · Letter from the SEC | Aug 19, 2016 | Other filings | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Guided Therapeutics, Inc.’s releases
- Common shares
- 96,537,349
- Fully diluted
- 96,537,349
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 96,537,349 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 96,537,349 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ronald W Allen Other companies: Forward Air Corporation (Director · Jan 19, 2011 – Aug 17, 2023 · Past); The Aaron's Company Inc. (CEO, Director · Feb 23, 2010 – Aug 14, 2014 · Past); Interstate Hotels & Resorts Inc (Director · Aug 24, 2006 – Mar 17, 2010 · Past); Aircastle Limited (Director · Aug 7, 2006 – Mar 27, 2020 · Past); Coca-Cola Company (the) (Director · Apr 3, 2006 – Apr 1, 2020 · Past) | Director · Sep 3, 2008 – Nov 27, 2013 · Past |
| Michael C James Other companies: Edible Garden AG Incorporated (Chief Financial Officer, Director · May 4, 2022 – Sep 14, 2022 · Past); Nestor Inc (Director · Jul 6, 2006 – Jul 27, 2007 · Past) | Director · Since at least Mar 19, 2007 |
| Gene S Cartwright Other companies: Nanosphere Inc (Director · Jun 20, 2013 – Jun 30, 2016 · Past) | President & CEO, Director · Jan 6, 2014 – Jun 29, 2015 · Past |
| Linda Rosenstock Other companies: Skilled Healthcare Group Inc (Director · Nov 18, 2009 – Aug 13, 2014 · Past) | Director · Apr 16, 2012 – Aug 14, 2014 · Past |
| Alan Grujic | Board Member · Since at least Mar 7, 2023 |
| John E Imhoff | Director · Since at least Jun 9, 2011 |
| Jonathan M Niloff | Director · Nov 3, 2011 – Aug 14, 2014 · Past |
| Mark A Samuels | CEO & CFO, Director · Mar 25, 2006 – Mar 12, 2007 · Past |
| Mark L. Faupel | President and CEO, Board Member · Since at least Nov 4, 2026 |
| Richard Fowler | V.P. Engineering · Feb 9, 2011 – Jun 29, 2012 · Past |
All 16 people
| Person | Seat |
|---|---|
| Richard P. Blumberg | Board Member · Since at least Nov 14, 2016 |
| Ronald W Hart | Director · Nov 3, 2011 – May 29, 2015 · Past |
| Shabbir Bakir Bambot | V.P.R & D, Director · Jun 21, 2007 – Jun 18, 2012 · Past |
| Siraj N Noorani | Chief Accounting Officer · May 4, 2006 – May 4, 2006 · Past |
| Walter J Pavlicek | VP of Operations · May 4, 2006 – May 4, 2006 · Past |
| William E Zachary Jr | Director · May 14, 2008 – Mar 31, 2010 · Past |
Log in to ask 6ix AI your own questions about Guided Therapeutics, Inc.